Director of Pharmacovigilance and Safety

1d1 day ago

Hippocratic AI

Palo Alto, US · Full-time · $260,000 – $340,000

About this role

Hippocratic AI is the leading generative AI company in healthcare with the only system capable of safe, autonomous clinical conversations with patients. The company has trained its own LLMs resulting in over 99.9% accuracy and is contracted with five of the top 20 pharma companies globally.

The Head of Pharmacovigilance and Safety will build and lead the safety infrastructure that enables the platform to operate credibly and compliantly across every patient interaction. This includes owning pharmacovigilance systems, adverse event processes, safety governance, and signal detection capabilities.

You will serve as the company's lead on drug safety, adverse event management, safety signal detection, and pharmacovigilance compliance with a focus on enabling enterprise sales to pharma and medtech partners. The role requires designing how pharmacovigilance works when the front line is an AI agent rather than a human representative.

This is one of the most creatively challenging safety roles in healthcare today. You will invent the frameworks, define the standards, and build the systems that become the industry blueprint for AI-enabled pharmacovigilance while working alongside experts from institutions such as Stanford, Johns Hopkins, Google, and NVIDIA.

Requirements

Expertise in building and managing pharmacovigilance programs and safety systems in regulated healthcare environments.
Deep knowledge of adverse event processes, safety governance, and signal detection capabilities.
Experience serving as lead on drug safety and pharmacovigilance compliance for life sciences organizations.
Ability to design pharmacovigilance frameworks specifically for AI agent interactions with patients.
Proven capability to create industry standards and systems for AI-enabled pharmacovigilance.

Responsibilities

Build and manage the pharmacovigilance programs, safety systems, and adverse event processes that support commercial growth.
Own pharmacovigilance systems, adverse event processes, safety governance, and signal detection capabilities.
Serve as the company's lead on drug safety, adverse event management, safety signal detection, and pharmacovigilance compliance.
Enable enterprise sales by ensuring pharma and medtech partners have full confidence in the platform's safety infrastructure.
Design how pharmacovigilance works when the front line is an AI agent conducting millions of patient interactions.
Invent the frameworks, define the standards, and build the systems that become the industry blueprint for AI-enabled pharmacovigilance.

Benefits

Work with physicians, hospital leaders, AI pioneers, and researchers from institutions like Stanford, Johns Hopkins, Google, Meta, and NVIDIA.
Backed by leading Life Science and AI investors with $404M total funding including a recent $126M Series C.